Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.40
+0.15 (1.82%)
At close: Aug 27, 2026, 4:00 PM EDT
8.41
+0.01 (0.12%)
After-hours: Aug 27, 2026, 7:59 PM EDT

ImmunityBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8,9031,9501,8693,3522,0762,419
Market Cap Growth
318.59%4.33%-44.23%61.49%-14.18%-
Enterprise Value
9,7742,5522,7593,8822,6762,681
Last Close Price
8.401.982.565.025.076.08

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
53.7017.22126.775388.888648.472589.53
PB Ratio
--3.90-3.83-5.72-4.61-9.92

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
58.9522.53187.096241.2011149.272870.55

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.17-1.69-1.62-1.51-1.61-2.66
Net Debt / Equity Ratio
-0.83-1.20-1.31-1.05-1.37-1.35
Net Debt / EBITDA Ratio
-3.70-2.50-1.96-1.80-1.86-1.09
Net Debt / FCF Ratio
-3.02-1.95-1.61-1.55-1.48-1.07
Asset Turnover
0.320.260.030.000.000.00
Inventory Turnover
0.260.16----
Quick Ratio
5.364.622.784.630.220.86
Current Ratio
5.725.103.365.050.280.91
Return on Assets (ROA)
-30.54%-36.17%-48.48%-52.11%-52.73%-57.48%
Return on Capital Employed (ROCE)
-45.60%-58.20%-104.90%-81.00%253.20%-317.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.15%-18.02%-22.13%-17.40%-20.07%-14.34%
FCF Yield
-3.24%-15.83%-21.30%-11.85%-20.03%-12.73%
Buyback Yield / Dilution
-26.61%-31.33%-37.71%-27.19%-2.74%-3.23%
SEC Filings: 10-K · 10-Q